Durvalumab with cetuximab and radiotherapy for locally advanced squamous cell carcinoma of the head and neck: A phase 1/2 trial-Reference-Cited by-同舟云学术

Durvalumab with cetuximab and radiotherapy for locally advanced squamous cell carcinoma of the head and neck: A phase 1/2 trial

Published:2022-04 Issue: Volume:169 Page:64-70
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Bonomo Pierluigi,Desideri Isacco,Mangoni Monica,Saieva Calogero,Loi Mauro,Becherini Carlotta,Cerbai Cecilia,Ganovelli Michele,Salvestrini Viola,Stocchi Giulia,Zani Margherita,Palomba Annarita,Livi Lorenzo

Funder

AstraZeneca

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference42 articles.

1. NCCN guidelines version 3.2021. Available at: www.nccn.org.

2. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients;Pignon;Radiother Oncol,2009

3. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group;Lacas;Radiother Oncol,2021

4. Evaluation of early and late toxicities in chemoradiation trials;Bentzen;J Clin Oncol,2007

5. Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis;Machtay;J Clin Oncol,2008

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evolving role of novel radiosensitizers and immune checkpoint inhibitors in (chemo)radiotherapy of locally advanced head and neck squamous cell carcinoma;Oral Oncology;2023-10

2. Curcumin Enhances the Efficacy of Docetaxel by Promoting Anti-Tumor Immune Response in Head and Neck Squamous Cell Carcinoma;Cancer Investigation;2023-03-30

3. Recent findings on the impact of ErbB receptors status on prognosis and therapy of head and neck squamous cell carcinoma;Frontiers in Medicine;2023-02-02